Abstract
Centrosome abnormalities have been observed in nearly all human solid tumors, but their role in tumorigenesis is unclear. We have demonstrated that autoantibodies reacting with antigens in centrosomes are frequently found in BC sera. In this work, we attempted to characterize the centrosome antigens associated with BC. We immunoscreened a T7 cDNA library of BC proteins with BC sera, and the autoantigens identified were printed as a microarray and hybridized with BC and control sera. We used immunohistochemistry (IHC) to investigate the expression of the cloned autoantigens in BC tissue. Immunoscreening with BC sera led to the cloning of autoantibodies recognizing epitopes developing in a family of proteins located on centrosomes such as peri-centriolar material-1, isomorph CRA, stathmin1, HS actin gamma1, SUMO/sentrin peptidase 2, and ubiquitin-conjugating enzyme E2 variant 1. Antibody reactivity to these proteins that are associated with centrosome assembly and/or microtubule function was highly associated with the diagnosis of BC. IHC staining of formalin-fixed paraffin-embedded sections with specific antibodies showed that aurora and stathmin are expressed in BC. The discovery of autoantibodies to important centrosome antigens associated with BC suggests that this immune reactivity could be related to autoimmunity developing in BC. Our finding that some of these antibodies are also present in a group of healthy women suggests that breakdown of tolerance to centrosome proteins may occur early in breast carcinogenesis and that autoantibodies to centrosome antigens might be biomarkers of early BC.
Similar content being viewed by others
References
Nigg EA, Stearns T. The centrosome cycle: centriole biogenesis, duplication and inherent asymmetries. Nat Cell Biol. 2011;13:1154–60.
Luders J, Stearns T. Microtubule-organizing centres: a re-evaluation. Nat Rev Mol Cell Biol. 2007;8:161–7.
Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol. 1997;13:83–117.
Zyss D, Gergely F. Centrosome function in cancer: guilty or innocent? Trends Cell Biol. 2009;7:334–46.
Kramer A, Neben K, Ho AD. Centrosome aberrations in hematological malignancies. Cell Biol Int. 2005;29:375–83.
Nigg EA. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer. 2002;2:815–25.
Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci USA. 1998;95:2950–5.
Giehl M, Fabarius A, Frank O, Hochhaus A, Hafner M, Hehlmann R, et al. Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability. Leukemia. 2005;19:1192–7.
Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998;58:3974–85.
Pihan GA, Wallace J, Zhou Y, Doxsey SJ. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 2003;63:1398–404.
Hardy PA, Zacharias H. Reappraisal of the Hansemann-Boveri hypothesis on the origin of tumors. Cell Biol Int. 2005;29:983–92.
Fernández-Madrid F, Tang N, Alansari H, et al. Autoantibodies to annexin XI-A and other autoantigens in the diagnosis of breast cancer. Cancer Res. 2004;64:5089–96.
Vader G, Lens S. The Aurora kinase family in cell division and cancer. Biochim Biophys Acta. 2008;1786:60–72.
Bieche I, Lachkar S, Becette V, et al. Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer. 1998;78:701–9.
Roos G, Brattsand G, Landberg G, Marklund U, Gullberg M. Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia. 1993;7:1538–46.
Price DK, Ball JR, Bahrani-Mostafavi Z, et al. The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancer. Cancer Invest. 2000;18:722–30.
Miller FR, Santner SJ, Tait L, Dawson PJ. LMCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst. 2000;92:1185–6.
Berg WA, Campassi C, Langenberg P, et al. Breast imaging reporting and data system. Inter- and intraobserver variability in feature analysis and final assessment. Am J Radiol. 2000;174:1769–77.
Altschul SF, Madden TL, Schäffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Res. 1997;25:3389–402.
Kent WJ. BLAT—the BLAST-like alignment tool. Genome Res. 2002;12:656–64.
Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FL, Gay LJ. Generation and initial analysis of more than 15,000 full length human cDNA sequences. Proc Nat Acad Sci USAS. 2001;99:16899–903.
Chang KW, Yang PY, Lai HY, Yeh TS, Chen TC, Yeh CT. Identification of a novel actin isoform in hepatocellular carcinoma. Hepatol Res. 2006;36:33–9.
Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Beasley E. The sequence of the human genome. Science. 2001;29:1304–51.
Sancho E, Vila MR, Sanchez-Pulido L, Lozana JJ, Paciucci R, Nadal M, Thomson TM. Role of UEV-1 an inactive variant of the E2 ubiquitin-conjugating enzymes, in differentiation and cell cycle behavior of HT-29-M6 intestinal secretory cells. Mol Cell Biol. 1998;18:576–87.
Gavanescu I, Vazquez-Abad D, McCauley J, Senecal JL, Doxsey S. Centrosome proteins: a major class of autoantigens in scleroderma. J Clin Immunol. 1999;19:166–71.
Howng SL, Chou AK, Lin CC, Lin ZA, Wang CJ, Loh JK, Lieu AS, Yen JH, Lee CI, Hong YR. Autoimmunity against hNinein, a human centrosomal protein, in patients with rheumatoid arthritis and systemic lupus erythematosus. Mol Med Rep. 2011;4:825–30.
Rattner JB, Fritzler MJ. Centriole and centrosome autoantibodies. In: Peter JB, Shoenfeld Y, editors. Autoantibodies. Amsterdam: Elsevier; 1996. p. 13–160.
Holmfeldt P, Stenmark S, Gullberg M. Interphase-specific phosphorylation-mediated regulation of tubulin dimer partitioning in human cells. Mol Biol Cell. 2007;18:1909–17.
Ringhoff DN, Cassimeris L. Stathmin regulates centrosomal nucleation of microtubules and tubulin dimer/polymer partitioning. Mol Biol Cell. 2009;20:3451–8.
Steinmetz MO. Structure and thermodynamics of the tubulin–stathmin interaction. J Struct Biol. 2007;158:137–47.
Friedrich B, Gronberg H, Landstrom M, Gullberg M, Bergh A. Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma. Prostate. 1995;27:102–9.
Hailat N, Strahler J, Melhem R, et al. N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18). Oncogene. 1990;5:1615–8.
Brattsand G. Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer. 2000;83:311–8.
Bieche I, Lachkar S, Becette V, et al. Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer. 1998;78:701–9.
Hanash SM, Strahler J, Kuick R, Chu EH, Nichols D. Identification of a polypeptide associated with the malignant phenotype in acute leukemia. J Biol Chem. 1988;263:12813–5.
Nylander K, Marklund U, Brattsand G, Gullberg M, Roos G. Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas. Histochem J. 1995;27:155–60.
Price DK, Ball JR, Bahrani-Mostafavi Z. The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancer. Cancer Invest. 2000;18:722–30.
Curmi PA, Nogues C, Lachkar S, Carelle N, Gonthier MP, Sobel A, Lidereau R, Bieche I. Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br J Cancer. 2000;82:142–50.
Wang F, Xuan XY, Yang X, Cao L, Pang LN, Zhou R, Fan QX, Wang LX. Stathmin is a marker of progression and poor prognosis in esophageal carcinoma. Asian Pac J Cancer Prev. 2014;15:3613–8.
Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, Wolf K, Canzonieri V, D’Andrea S, Zucchetto A, Friedl P, Colombatti A, Baldassarre G. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell. 2008;19:2000–13.
Balczon R, Bao L, Zimmer WE. PCM-1, a 228-kD centrosome autoantigen with a distinct cell cycle distribution. J Cell Biol. 1994;124:783–93.
Kubo A, Sasaki H, Yuba-Kubo A, Tsukita S, Shiina N. Centriolar satellites: molecular characterization, ATP-dependent movement toward centrioles and possible involvement in ciliogenesis. J Cell Biol. 1999;147:969–79.
Dammermann A, Merdes A. Assembly of centrosomal proteins and microtubule organization depends on PCM-1. J Cell Biol. 2002;159(2):255–66.
Bao L, Zimmer WE, Balczon R. Autoepitope mapping of the centrosome autoantigen PCM-1 using scleroderma sera with anticentrosome autoantibodies. Autoimmunity. 1995;22:219–28.
Vaughan Sue, Dawe Helen R. Common themes in centriole and centrosome movements. Trends Cell Biol. 2011;21:57–66.
Euteneuer U, Schliwa M. Evidence for an involvement of actin in the positioning and motility of centrosomes. J Cell Biol. 1985;101:96–103.
Yamazaki D, Kurisu S, Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci. 2005;96:379–86.
Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2007;1773:642–52.
Habermann K, Lange BM. New insights into subcomplex assembly and modifications of centrosomal proteins. Cell Div. 2012;7:17.
Mani A, Gelmann EP. The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol. 2005;23:4776–89.
Honda K, Mihara H, Kato Y, et al. Degradation of human Aurora 2 protein kinase by the anaphase-promoting complex–ubiquitin–proteasome pathway. Oncogene. 2000;19:2812–9.
Ban R, Tamotsu N, Takeshi U. Mitotic kinase Aurora-B is regulated by SUMO-2 conjugation deconjugation during mitosis. Genes Cells. 2011;16:652–69.
Katayam H, Brinkley WR, Sen S. The aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 2003;22:451–64.
Tanaka T, Kimura M, Matsunga K, Fukada D, Mori H, Okano Y. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 1999;59:2041–4.
Goepfert TM, Adigun YE, Zhong L, Gay J, Medina D, Brinkley WR. Centrosome amplification and overexpression of Aurora A are early events in rat mammary carcinogenesis. Cancer Res. 2012;62:4115–22.
Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Investig. 2001;108:1411–5.
Koziol JA, Zhang JY, Casiano CA, Peng XX, Shi FD, Feng AC, Chan EK, Tan EM. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin Cancer Res. 2003;9:5120–6.
Hanash S. Disease proteomics. Nature. 2003;422:226–32.
Chapman C, Murray A, Chakrabarti J, Thorpe A, Woolston C, Sahin U, Barnes A, Robertson J. Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol. 2007;18:868–73.
Acknowledgments
This work was done with the partial support of NIH NCI R01 122277. We thank the technical work of Naimei Tang and Xinbo Zhang in several aspects of this project.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maroun, MC., Olivero, O., Lipovich, L. et al. Anti-centrosome antibodies in breast cancer are the expression of autoimmunity. Immunol Res 60, 339–347 (2014). https://doi.org/10.1007/s12026-014-8582-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-014-8582-4